1 / 6

North America IVD Market Innovation and Product Optimization to Boost Growth

The North America IVD Market is accounted for $20,886 million in 2016, and is estimated to reach $27.820 million by 2023, growing at a CAGR of 4.1% during the analysis period 2017-2023.

newmarketindustry
Download Presentation

North America IVD Market Innovation and Product Optimization to Boost Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. North America IVD Market

  2. The North America IVD Market is accounted for $20,886 million in 2016, and is estimated to reach $27.820 million by 2023, growing at a CAGR of 4.1% during the analysis period 2017-2023. IVD products are those agents, instruments, and systems utilized to examine samples such as blood, urine, stool, tissues, and other body fluids. Get Sample Report

  3. These samples are derived from the human body to detect diseases, conditions, and infections. The tests can be performed in standalone laboratory, and hospital-based laboratory. IVD utilizes several techniques, such as polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry for test sample preparation to detect diseases. Rise in incidence & prevalence of chronic diseases, technological advancements in testing techniques, and the increase in healthcare expenditure fuel the market growth during the analysis period. However, stringent regulatory policies and unclear reimbursement policies restrict the growth.

  4. Based on product type, the market is categorized into reagents, instruments, and software & services. The reagent segment accounted for the highest market share in 2016, and the software and services is expected to grow at the highest growth rate during the forecast period. The growth of the reagent market is attributed to the recent introduction of new novel reagents and wide availability of effective and cost-efficient reagents. On the basis of technique, the immunodiagnostics segment captured the highest market share in 2016, due to the increase in demand of personalized medicines.

  5. Key Market Benefits: • The study provides an in-depth analysis of the North America IVD market with current trends and future estimations to elucidate the imminent investment pockets. • The report provides a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities • Extensive analysis by technology and application helps understand various trends and prevailing opportunities in the respective market • Comprehensive analysis of all geographical regions is provided, which determines the main opportunities in these geographies • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which predict the competitive outlook of the North America IVD

  6. Major companies operating in this market adopt product launch as their key development strategy. Companies profiled in this market include, Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson among others.

More Related